Cargando…
Combating Drug Resistant Pathogenic Bacteria Isolated from Clinical Infections, with Silver Oxide Nanoparticles
The antibiogram study of methicillin resistant Staphylococcus aureus isolates revealed 100% resistance to vancomycin, bacitracin, erythromycin, ciprofloxacin and nalidixic acid. Eight isolates (53.3%) showed resistance to co-trimoxazole and one isolate to rifampicin, which was the drug of choice. An...
Autores principales: | Sangappa, M., Thiagarajan, Padma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4442462/ https://www.ncbi.nlm.nih.gov/pubmed/26009646 |
Ejemplares similares
-
Silver Nanoparticle-Based Therapy: Can It Be Useful to Combat Multi-Drug Resistant Bacteria?
por: Mateo, Eva M., et al.
Publicado: (2022) -
Silver-Containing Titanium Dioxide Nanocapsules for Combating Multidrug-Resistant Bacteria
por: Hérault, Nelly, et al.
Publicado: (2020) -
Repurposing Clinical Molecule Ebselen to Combat Drug Resistant Pathogens
por: Thangamani, Shankar, et al.
Publicado: (2015) -
Silver Nanoparticle-Based Nanocomposites for Combating Infectious Pathogens: Recent Advances and Future Prospects
por: Wahab, Md A., et al.
Publicado: (2021) -
Dihydroxy‐Acid Dehydratases From Pathogenic Bacteria: Emerging Drug Targets to Combat Antibiotic Resistance
por: Bayaraa, Tenuun, et al.
Publicado: (2022)